Segregation analysis of plasminogen activator inhibitor-1 and fibrinogen levels in the NHLBI family heart study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 10, 1998, Pages 1559-1567

  Pankow, James S ^a   Folsom, Aaron R ^b   Province, Michael A ^d   Rao, D C ^d   Williams, Roger R ^e   Eckfeldt, John ^c   Sellers, Thomas A ^b  

^a IL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF UTAH   (United States)

Author keywords

Fibrinogen; Heritability; Plasminogen activator inhibitor 1; Segregation analysis

Indexed keywords

FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CORRELATION FUNCTION; ENVIRONMENTAL FACTOR; FAMILIAL DISEASE; FAMILY HISTORY; FEMALE; FIBRINOGEN BLOOD LEVEL; GENETIC RISK; HERITABILITY; HUMAN; ISCHEMIC HEART DISEASE; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SEGREGATION ANALYSIS;

EID: 0031667374     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.10.1559     Document Type: Article

References (16)

1. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986;2:533-537.
2. Heinrich J, Balleisen L, Schulte H, Assman G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM study in healthy men. Arterioscler Thromb. 1994;14:54-59.
3. Hamsten A, De Faire U, Walldius G, Dahlen G, Szamosi A, Landou C, Blomback M, Wiman B. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet. 1987;2:3-9.
4. Juhan-Vague I, Pyke SDM, Alessi MC, Jespersen J, Haverkate F, Thompson SG. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. Circulation. 1996;94: 2057-2063.
5. Tracy RP, Bovill EG. Thrombosis and cardiovascular risk in the elderly. Arch Pathol Lab Med. 1992;116:1307-1312.
6. Higgins M, Province M, Heiss G, Eckfeldt J, Ellison C, Folsom A, Rao DC, Sprafka M, Williams R, for the NHLBI Family Heart Study Investigators. The NHLBI Family Heart Study: objectives and design. Am J Epidemiol. 1996;143:1219-1228.
7. de Clerck PJ, Alessim C, Verstreken M, Kruithof EK, Juhan-Vague I, Collen D. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood. 1988;71:220-225.
8. Clauss A. Gerinnungsphysiologische Schnellmethode zur bestimmung des Fibrinogens. Acta Haematol. 1957;17:237-246.
9. Province MA, Rao DC. General purpose model and a computer program for combined segregation and path analysis (SEGPATH): automatically creating computer programs from symbolic language model specifications. Genet Epidemiol. 1995;12:203-219.
10. Falconer DS. Introduction to Quantitative Genetics. 3rd ed. New York, NY: Wiley; 1989.
11. Bonney GE. Regressive logistic models for familial disease and other binary traits. Biometrics. 1986;42:611-625.
12. Statistical Analysis for Genetic Epidemiology, release 2.2. Cleveland, Ohio: Department Epidemiology and of Biostatistics, Case Western Reserve University; 1994.
13. Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control. 1974;19:716-726.
14. Cannings E, Thompson EA, Skolnick MH. Probability functions on complex pedigrees. Adv Appl Probl. 1978;10:26-61.
15. Lalouel JM, Rao DC, Morton NE, Elston RC. A unified model for complex segregation analysis. Am J Hum Genet. 1983;35:816-826.
16. Beaty TH. Evolving methods in genetic epidemiology, I: analysis of genetic and environmental factors in family studies. Epidemiol Rev. 1997;19:14-23.